Dinaciclib ( MK-7965 , formerly SCH 727965 ) , a novel , small-molecule inhibitor of cyclin-dependent kinases , has been shown to induce apoptosis in preclinical studies of human tumor cell lines , including non-small cell lung cancer ( NSCLC ) cells .